Loading…

Spatial Characteristics of the Efflux Pump MexB Determine Inhibitor Binding

The multidrug efflux transporters MexB and MexY in Pseudomonas aeruginosa and AcrB in Escherichia coli contribute to these organisms' multidrug resistance. Efflux pump inhibitor (EPI) ABI-PP inhibits MexB and AcrB, but not MexY. We previously determined the structure of ABI-PP bound to the hydr...

Full description

Saved in:
Bibliographic Details
Published in:Antimicrobial agents and chemotherapy 2022-11, Vol.66 (11), p.e0067222-e0067222
Main Authors: Yamasaki, Seiji, Koga, Naoki, Zwama, Martijn, Sakurai, Keisuke, Nakashima, Ryosuke, Yamaguchi, Akihito, Nishino, Kunihiko
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-a484t-a8a20a04fc6272fd6b354019d260dc3cf21c5e69fe91f6cb13ac051f9a94ad213
cites cdi_FETCH-LOGICAL-a484t-a8a20a04fc6272fd6b354019d260dc3cf21c5e69fe91f6cb13ac051f9a94ad213
container_end_page e0067222
container_issue 11
container_start_page e0067222
container_title Antimicrobial agents and chemotherapy
container_volume 66
creator Yamasaki, Seiji
Koga, Naoki
Zwama, Martijn
Sakurai, Keisuke
Nakashima, Ryosuke
Yamaguchi, Akihito
Nishino, Kunihiko
description The multidrug efflux transporters MexB and MexY in Pseudomonas aeruginosa and AcrB in Escherichia coli contribute to these organisms' multidrug resistance. Efflux pump inhibitor (EPI) ABI-PP inhibits MexB and AcrB, but not MexY. We previously determined the structure of ABI-PP bound to the hydrophobic trap (the inhibitor-binding pit) of AcrB and MexB. The insensitivity of MexY to ABI-PP was attributed to a bulky tryptophan (Trp). AcrB(Phe178Trp) became uninhibited by ABI-PP, while MexY(Trp177Phe) resensitized MexY for ABI-PP. Interestingly, ABI-PP was able to inhibit MexB(Phe178Trp). Thus, it is not clear which bulky amino acid mutations are critical for inhibitor binding in MexB. Here, we investigated the pit of MexB in more detail, and elucidated which Trp mutation locations in the pit were hindering ABI-PP binding, but did not affect the function of the efflux pumps. Mutating positions 139, 277, 279, and 612 to tryptophan eliminated the inhibitory effect. However, the tryptophan mutation at position 571 did not cause any effect. These results show that the effectiveness of EPIs is greatly affected by mutations in different locations, and that binding of EPIs is partly attributed by spatial characteristics. These results should be taken into account for new inhibitor and drug discovery.
doi_str_mv 10.1128/aac.00672-22
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9664856</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2729515701</sourcerecordid><originalsourceid>FETCH-LOGICAL-a484t-a8a20a04fc6272fd6b354019d260dc3cf21c5e69fe91f6cb13ac051f9a94ad213</originalsourceid><addsrcrecordid>eNp1kU1LxDAQhoMouq7ePEuOClaTtMk2F0HX9QMVBfUcpmmyzdIvk1b031tdFT14Gmbm4Z2ZdxDaoeSQUpYeAehDQsSERYytoBElMo0El2IVjYayiJKUJBtoM4QFGXIuyTraiEVMiIz5CF0_tNA5KPG0AA-6M96FzumAG4u7wuCZtWX_iu_7qsW35vUUn5mBqVxt8FVduMx1jcenrs5dPd9CaxbKYLa_4hg9nc8ep5fRzd3F1fTkJoIkTboIUmAESGK1YBNmc5HFPCFU5kyQXMfaMqq5EdIaSa3QGY1BE06tBJlAzmg8RsdL3bbPKpNrU3ceStV6V4F_Uw049bdTu0LNmxclhUhSLgaBvS8B3zz3JnSqckGbsoTaNH1Qw1qSUz4hH7MOlqj2TQje2J8xlKgP_9Xgv_r0XzE24PtLHELF1KLpfT048R-7-_uMH-Hv58TvRz2Onw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2729515701</pqid></control><display><type>article</type><title>Spatial Characteristics of the Efflux Pump MexB Determine Inhibitor Binding</title><source>American Society for Microbiology Journals</source><source>PubMed Central</source><creator>Yamasaki, Seiji ; Koga, Naoki ; Zwama, Martijn ; Sakurai, Keisuke ; Nakashima, Ryosuke ; Yamaguchi, Akihito ; Nishino, Kunihiko</creator><creatorcontrib>Yamasaki, Seiji ; Koga, Naoki ; Zwama, Martijn ; Sakurai, Keisuke ; Nakashima, Ryosuke ; Yamaguchi, Akihito ; Nishino, Kunihiko</creatorcontrib><description>The multidrug efflux transporters MexB and MexY in Pseudomonas aeruginosa and AcrB in Escherichia coli contribute to these organisms' multidrug resistance. Efflux pump inhibitor (EPI) ABI-PP inhibits MexB and AcrB, but not MexY. We previously determined the structure of ABI-PP bound to the hydrophobic trap (the inhibitor-binding pit) of AcrB and MexB. The insensitivity of MexY to ABI-PP was attributed to a bulky tryptophan (Trp). AcrB(Phe178Trp) became uninhibited by ABI-PP, while MexY(Trp177Phe) resensitized MexY for ABI-PP. Interestingly, ABI-PP was able to inhibit MexB(Phe178Trp). Thus, it is not clear which bulky amino acid mutations are critical for inhibitor binding in MexB. Here, we investigated the pit of MexB in more detail, and elucidated which Trp mutation locations in the pit were hindering ABI-PP binding, but did not affect the function of the efflux pumps. Mutating positions 139, 277, 279, and 612 to tryptophan eliminated the inhibitory effect. However, the tryptophan mutation at position 571 did not cause any effect. These results show that the effectiveness of EPIs is greatly affected by mutations in different locations, and that binding of EPIs is partly attributed by spatial characteristics. These results should be taken into account for new inhibitor and drug discovery.</description><identifier>ISSN: 0066-4804</identifier><identifier>EISSN: 1098-6596</identifier><identifier>DOI: 10.1128/aac.00672-22</identifier><identifier>PMID: 36300935</identifier><language>eng</language><publisher>United States: American Society for Microbiology</publisher><subject>Anti-Bacterial Agents - chemistry ; Bacterial Outer Membrane Proteins - metabolism ; Bacteriology ; Escherichia coli - genetics ; Escherichia coli - metabolism ; Escherichia coli Proteins - metabolism ; Mechanisms of Resistance ; Membrane Transport Proteins - metabolism ; Multidrug Resistance-Associated Proteins - genetics ; Multidrug Resistance-Associated Proteins - metabolism ; Pseudomonas aeruginosa ; Tryptophan - pharmacology</subject><ispartof>Antimicrobial agents and chemotherapy, 2022-11, Vol.66 (11), p.e0067222-e0067222</ispartof><rights>Copyright © 2022 Yamasaki et al.</rights><rights>Copyright © 2022 Yamasaki et al. 2022 Yamasaki et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a484t-a8a20a04fc6272fd6b354019d260dc3cf21c5e69fe91f6cb13ac051f9a94ad213</citedby><cites>FETCH-LOGICAL-a484t-a8a20a04fc6272fd6b354019d260dc3cf21c5e69fe91f6cb13ac051f9a94ad213</cites><orcidid>0000-0001-9081-382X ; 0000-0003-3349-1769</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.asm.org/doi/pdf/10.1128/aac.00672-22$$EPDF$$P50$$Gasm2$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://journals.asm.org/doi/full/10.1128/aac.00672-22$$EHTML$$P50$$Gasm2$$Hfree_for_read</linktohtml><link.rule.ids>230,315,733,786,790,891,3207,27957,27958,52786,52787,52788,53827,53829</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36300935$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yamasaki, Seiji</creatorcontrib><creatorcontrib>Koga, Naoki</creatorcontrib><creatorcontrib>Zwama, Martijn</creatorcontrib><creatorcontrib>Sakurai, Keisuke</creatorcontrib><creatorcontrib>Nakashima, Ryosuke</creatorcontrib><creatorcontrib>Yamaguchi, Akihito</creatorcontrib><creatorcontrib>Nishino, Kunihiko</creatorcontrib><title>Spatial Characteristics of the Efflux Pump MexB Determine Inhibitor Binding</title><title>Antimicrobial agents and chemotherapy</title><addtitle>Antimicrob Agents Chemother</addtitle><addtitle>Antimicrob Agents Chemother</addtitle><description>The multidrug efflux transporters MexB and MexY in Pseudomonas aeruginosa and AcrB in Escherichia coli contribute to these organisms' multidrug resistance. Efflux pump inhibitor (EPI) ABI-PP inhibits MexB and AcrB, but not MexY. We previously determined the structure of ABI-PP bound to the hydrophobic trap (the inhibitor-binding pit) of AcrB and MexB. The insensitivity of MexY to ABI-PP was attributed to a bulky tryptophan (Trp). AcrB(Phe178Trp) became uninhibited by ABI-PP, while MexY(Trp177Phe) resensitized MexY for ABI-PP. Interestingly, ABI-PP was able to inhibit MexB(Phe178Trp). Thus, it is not clear which bulky amino acid mutations are critical for inhibitor binding in MexB. Here, we investigated the pit of MexB in more detail, and elucidated which Trp mutation locations in the pit were hindering ABI-PP binding, but did not affect the function of the efflux pumps. Mutating positions 139, 277, 279, and 612 to tryptophan eliminated the inhibitory effect. However, the tryptophan mutation at position 571 did not cause any effect. These results show that the effectiveness of EPIs is greatly affected by mutations in different locations, and that binding of EPIs is partly attributed by spatial characteristics. These results should be taken into account for new inhibitor and drug discovery.</description><subject>Anti-Bacterial Agents - chemistry</subject><subject>Bacterial Outer Membrane Proteins - metabolism</subject><subject>Bacteriology</subject><subject>Escherichia coli - genetics</subject><subject>Escherichia coli - metabolism</subject><subject>Escherichia coli Proteins - metabolism</subject><subject>Mechanisms of Resistance</subject><subject>Membrane Transport Proteins - metabolism</subject><subject>Multidrug Resistance-Associated Proteins - genetics</subject><subject>Multidrug Resistance-Associated Proteins - metabolism</subject><subject>Pseudomonas aeruginosa</subject><subject>Tryptophan - pharmacology</subject><issn>0066-4804</issn><issn>1098-6596</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp1kU1LxDAQhoMouq7ePEuOClaTtMk2F0HX9QMVBfUcpmmyzdIvk1b031tdFT14Gmbm4Z2ZdxDaoeSQUpYeAehDQsSERYytoBElMo0El2IVjYayiJKUJBtoM4QFGXIuyTraiEVMiIz5CF0_tNA5KPG0AA-6M96FzumAG4u7wuCZtWX_iu_7qsW35vUUn5mBqVxt8FVduMx1jcenrs5dPd9CaxbKYLa_4hg9nc8ep5fRzd3F1fTkJoIkTboIUmAESGK1YBNmc5HFPCFU5kyQXMfaMqq5EdIaSa3QGY1BE06tBJlAzmg8RsdL3bbPKpNrU3ceStV6V4F_Uw049bdTu0LNmxclhUhSLgaBvS8B3zz3JnSqckGbsoTaNH1Qw1qSUz4hH7MOlqj2TQje2J8xlKgP_9Xgv_r0XzE24PtLHELF1KLpfT048R-7-_uMH-Hv58TvRz2Onw</recordid><startdate>20221115</startdate><enddate>20221115</enddate><creator>Yamasaki, Seiji</creator><creator>Koga, Naoki</creator><creator>Zwama, Martijn</creator><creator>Sakurai, Keisuke</creator><creator>Nakashima, Ryosuke</creator><creator>Yamaguchi, Akihito</creator><creator>Nishino, Kunihiko</creator><general>American Society for Microbiology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-9081-382X</orcidid><orcidid>https://orcid.org/0000-0003-3349-1769</orcidid></search><sort><creationdate>20221115</creationdate><title>Spatial Characteristics of the Efflux Pump MexB Determine Inhibitor Binding</title><author>Yamasaki, Seiji ; Koga, Naoki ; Zwama, Martijn ; Sakurai, Keisuke ; Nakashima, Ryosuke ; Yamaguchi, Akihito ; Nishino, Kunihiko</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a484t-a8a20a04fc6272fd6b354019d260dc3cf21c5e69fe91f6cb13ac051f9a94ad213</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Anti-Bacterial Agents - chemistry</topic><topic>Bacterial Outer Membrane Proteins - metabolism</topic><topic>Bacteriology</topic><topic>Escherichia coli - genetics</topic><topic>Escherichia coli - metabolism</topic><topic>Escherichia coli Proteins - metabolism</topic><topic>Mechanisms of Resistance</topic><topic>Membrane Transport Proteins - metabolism</topic><topic>Multidrug Resistance-Associated Proteins - genetics</topic><topic>Multidrug Resistance-Associated Proteins - metabolism</topic><topic>Pseudomonas aeruginosa</topic><topic>Tryptophan - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yamasaki, Seiji</creatorcontrib><creatorcontrib>Koga, Naoki</creatorcontrib><creatorcontrib>Zwama, Martijn</creatorcontrib><creatorcontrib>Sakurai, Keisuke</creatorcontrib><creatorcontrib>Nakashima, Ryosuke</creatorcontrib><creatorcontrib>Yamaguchi, Akihito</creatorcontrib><creatorcontrib>Nishino, Kunihiko</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Antimicrobial agents and chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yamasaki, Seiji</au><au>Koga, Naoki</au><au>Zwama, Martijn</au><au>Sakurai, Keisuke</au><au>Nakashima, Ryosuke</au><au>Yamaguchi, Akihito</au><au>Nishino, Kunihiko</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Spatial Characteristics of the Efflux Pump MexB Determine Inhibitor Binding</atitle><jtitle>Antimicrobial agents and chemotherapy</jtitle><stitle>Antimicrob Agents Chemother</stitle><addtitle>Antimicrob Agents Chemother</addtitle><date>2022-11-15</date><risdate>2022</risdate><volume>66</volume><issue>11</issue><spage>e0067222</spage><epage>e0067222</epage><pages>e0067222-e0067222</pages><issn>0066-4804</issn><eissn>1098-6596</eissn><notes>ObjectType-Article-1</notes><notes>SourceType-Scholarly Journals-1</notes><notes>ObjectType-Feature-2</notes><notes>content type line 23</notes><notes>The authors declare no conflict of interest.</notes><notes>Present address: Keisuke Sakurai, Institute for Protein Research, Osaka University, Suita, Osaka, Japan.</notes><abstract>The multidrug efflux transporters MexB and MexY in Pseudomonas aeruginosa and AcrB in Escherichia coli contribute to these organisms' multidrug resistance. Efflux pump inhibitor (EPI) ABI-PP inhibits MexB and AcrB, but not MexY. We previously determined the structure of ABI-PP bound to the hydrophobic trap (the inhibitor-binding pit) of AcrB and MexB. The insensitivity of MexY to ABI-PP was attributed to a bulky tryptophan (Trp). AcrB(Phe178Trp) became uninhibited by ABI-PP, while MexY(Trp177Phe) resensitized MexY for ABI-PP. Interestingly, ABI-PP was able to inhibit MexB(Phe178Trp). Thus, it is not clear which bulky amino acid mutations are critical for inhibitor binding in MexB. Here, we investigated the pit of MexB in more detail, and elucidated which Trp mutation locations in the pit were hindering ABI-PP binding, but did not affect the function of the efflux pumps. Mutating positions 139, 277, 279, and 612 to tryptophan eliminated the inhibitory effect. However, the tryptophan mutation at position 571 did not cause any effect. These results show that the effectiveness of EPIs is greatly affected by mutations in different locations, and that binding of EPIs is partly attributed by spatial characteristics. These results should be taken into account for new inhibitor and drug discovery.</abstract><cop>United States</cop><pub>American Society for Microbiology</pub><pmid>36300935</pmid><doi>10.1128/aac.00672-22</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0001-9081-382X</orcidid><orcidid>https://orcid.org/0000-0003-3349-1769</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0066-4804
ispartof Antimicrobial agents and chemotherapy, 2022-11, Vol.66 (11), p.e0067222-e0067222
issn 0066-4804
1098-6596
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9664856
source American Society for Microbiology Journals; PubMed Central
subjects Anti-Bacterial Agents - chemistry
Bacterial Outer Membrane Proteins - metabolism
Bacteriology
Escherichia coli - genetics
Escherichia coli - metabolism
Escherichia coli Proteins - metabolism
Mechanisms of Resistance
Membrane Transport Proteins - metabolism
Multidrug Resistance-Associated Proteins - genetics
Multidrug Resistance-Associated Proteins - metabolism
Pseudomonas aeruginosa
Tryptophan - pharmacology
title Spatial Characteristics of the Efflux Pump MexB Determine Inhibitor Binding
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-21T08%3A45%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Spatial%20Characteristics%20of%20the%20Efflux%20Pump%20MexB%20Determine%20Inhibitor%20Binding&rft.jtitle=Antimicrobial%20agents%20and%20chemotherapy&rft.au=Yamasaki,%20Seiji&rft.date=2022-11-15&rft.volume=66&rft.issue=11&rft.spage=e0067222&rft.epage=e0067222&rft.pages=e0067222-e0067222&rft.issn=0066-4804&rft.eissn=1098-6596&rft_id=info:doi/10.1128/aac.00672-22&rft_dat=%3Cproquest_pubme%3E2729515701%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-a484t-a8a20a04fc6272fd6b354019d260dc3cf21c5e69fe91f6cb13ac051f9a94ad213%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2729515701&rft_id=info:pmid/36300935&rfr_iscdi=true